SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:gup.ub.gu.se/185476"
 

Search: id:"swepub:oai:gup.ub.gu.se/185476" > Immunotherapeutic s...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Immunotherapeutic strategies for relapse control in acute myeloid leukemia

Martner, Anna, 1979 (author)
Gothenburg University,Göteborgs universitet,Sahlgrenska Cancer Center
Bergh Thorén, Fredrik, 1976 (author)
Gothenburg University,Göteborgs universitet,Sahlgrenska Cancer Center
Aurelius, Johan, 1980 (author)
Gothenburg University,Göteborgs universitet,Sahlgrenska Cancer Center
show more...
Hellstrand, Kristoffer, 1956 (author)
Gothenburg University,Göteborgs universitet,Sahlgrenska Cancer Center
show less...
 (creator_code:org_t)
Elsevier BV, 2013
2013
English.
In: Blood Reviews. - : Elsevier BV. - 0268-960X. ; 27:5, s. 209-216
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Despite that the initial phases of chemotherapy induce disappearance of leukemic cells in many patients with acute myeloid leukemia (AML), the prevention of life-threatening relapses in the post-remission phase remains a significant clinical challenge. Allogeneic bone marrow transplantation, which is available for a minority of patients, efficiently prevents recurrences of leukemia by inducing immune-mediated elimination of leukemic cells, and over the past decades, numerous immunotherapeutic protocols have been developed aiming to mimic the graft-versus-leukemia reaction for the prevention of relapse. Here we review past and present strategies for relapse control with focus on overcoming leukemia-related immunosuppression in AML. We envisage future treatment protocols, in which systemic immune activators, such as vaccines, dendritic cell-based therapies, engineered variants of IL-2, or IL-15, are combined with agents that counter immunosuppression mediated by, e.g., the PD/PDL interaction, CTLA-4, CD200, reactive oxygen species, IDO expression, CXCR4, or the KIR/class I interaction, based on characteristics of the prevailing malignant clone. This combinatorial approach may pave the way for individualized immunotherapy in AML.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Acute myeloid leukemia
Maintenance therapy
Leukemia-related immunosuppression
REGULATORY T-CELLS
ACUTE MYELOGENOUS LEUKEMIA
BONE-MARROW-TRANSPLANTATION
POST-CONSOLIDATION IMMUNOTHERAPY
REMISSION
MAINTENANCE THERAPY
ACUTE PROMYELOCYTIC LEUKEMIA
KIR LIGAND
INCOMPATIBILITY
HUMORAL IMMUNE-RESPONSES
1ST COMPLETE REMISSION
LOW-DOSE INTERLEUKIN-2

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Martner, Anna, 1 ...
Bergh Thorén, Fr ...
Aurelius, Johan, ...
Hellstrand, Kris ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
and Cancer and Oncol ...
Articles in the publication
Blood Reviews
By the university
University of Gothenburg

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view